高级检索
当前位置: 首页 > 详情页

The Comparison of Two Whole-Genome Amplification Approaches for Noninvasive Preimplantation Genetic Testing (ni-PGT) and the Application Scenario of ni-PGT during the Fresh Cycle

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]First Peoples Hosp Yunnan Prov, Dept Reprod Med, Kunming, Peoples R China [2]Kunming Univ Sci & Technol, Affiliated Hosp, Kunming, Peoples R China [3]Natl Hlth Commiss Key Lab Preconcept Hlth Birth We, Kunming, Peoples R China [4]First Peoples Hosp Yunnan Prov, Dept Repro duct Med, 157 Jinbi Rd, Kunming 650034, Yunnan, Peoples R China
出处:
ISSN:

摘要:
Recently, noninvasive preimplantation genetic testing (ni-PGT) using degenerate oligonucleotide primer PCR (DOP-PCR) and multiple annealing and looping-based amplification cycle (MALBAC)-based whole-genome amplification (WGA) methods has demonstrated predictable results in embryo testing. However, a considerable heterogeneity of results has been reported in numerous studies on these two WGA methods. Our aim was to evaluate the current WGA method for ni-PGT while further clarifying the applicable scenarios of ni-PGT in the fresh cycle. A total of 173 embryos were tested with trophectoderm biopsy and ni-PGT. In the whole preimplantation genetic testing, the clinical concordance rates of the detection results of DOP-PCR and MALBAC with the corresponding trophectoderm biopsy results were 64.12% (84/131) and 68.99% (89/129), respectively (P = 0.405). However, in the detection of abnormal embryos, the detection efficiency of ni-PGT is significantly improved [MALBAC: 96.55% versus 68.99% (P < 0.001); and DOP-PCR: 89.09% versus 64.12% (P < 0.001)]. In addition, the diagnostic efficiency of ni-PGT in low-quality blastocysts was significantly higher than that in high-quality blastocysts [MALBAC: 95.24% versus 51.85% (P = 0.001); and DOP-PCR: 91.30% versus 48.15% (P = 0.001)]. These results contribute to further understanding ni-PGT and to clarifying its application scenario in the fresh cycle.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 3 区 医学
小类 | 2 区 病理学
最新[2025]版:
大类 | 3 区 医学
小类 | 2 区 病理学
JCR分区:
出版当年[2022]版:
Q2 PATHOLOGY
最新[2024]版:
Q1 PATHOLOGY

影响因子: 最新[2024版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者机构: [1]First Peoples Hosp Yunnan Prov, Dept Reprod Med, Kunming, Peoples R China [2]Kunming Univ Sci & Technol, Affiliated Hosp, Kunming, Peoples R China [3]Natl Hlth Commiss Key Lab Preconcept Hlth Birth We, Kunming, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [1]First Peoples Hosp Yunnan Prov, Dept Reprod Med, Kunming, Peoples R China [2]Kunming Univ Sci & Technol, Affiliated Hosp, Kunming, Peoples R China [3]Natl Hlth Commiss Key Lab Preconcept Hlth Birth We, Kunming, Peoples R China [4]First Peoples Hosp Yunnan Prov, Dept Repro duct Med, 157 Jinbi Rd, Kunming 650034, Yunnan, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:92452 今日访问量:0 总访问量:782 更新日期:2025-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号 ICP备案:滇ICP备15003244号